A2 Biotherapeutics
Latest round
- Series C
Last raised
- Jan 2025
Total raised
- $209M
Investors
- 8
About A2 Biotherapeutics
A2 Biotherapeutics, Inc.Founded in 2018 and headquartered in Agoura Hills, California, A2 Biotherapeutics, Inc. develops T cell therapies aimed at treating various forms of solid tumors. The company was established by Michael Gallo, who has a background in leading biotech ventures.A2 Biotherapeutics specializes in innovative cell therapies for solid tumors, focusing on its proprietary Tmod™ precision-targeting platform. This platform allows for a modular approach in identifying and targeting specific gene losses in cancer cells while sparing healthy cells. Their offerings include both autologous and allogeneic T cell therapies designed to overcome limitations of traditional therapies by integrating multiple signals.A2 Biotherapeutics employs a structured revenue model based on partnerships with healthcare institutions and clinical trial collaborations. The company generates revenue through agreements with hospitals and research organizations, granting them access to advanced T cell therapy solutions. The company is focused on expanding its market presence in North America and Europe and aims to launch new products that leverage its Tmod™ platform to address additional cancer types. A2 Biotherapeutics is strategically positioned to enhance its offerings and potentially explore new geographic regions to optimize its impact in the oncology therapeutic landscape.
Who invested in A2 Biotherapeutics
8 investors across 4 rounds
See all investors in A2 Biotherapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about A2 Biotherapeutics
Who invested in A2 Biotherapeutics?
A2 Biotherapeutics has 8 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has A2 Biotherapeutics raised?
A2 Biotherapeutics has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did A2 Biotherapeutics last raise money?
A2 Biotherapeutics's most recent round on record is a Series C, in Jan 2025.
What does A2 Biotherapeutics do?
A2 Biotherapeutics is a biotechnology company.
Where is A2 Biotherapeutics headquartered?
A2 Biotherapeutics is headquartered in Agoura Hills, US.
Which VCs invest in companies like A2 Biotherapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at A2 Biotherapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like A2 Biotherapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.